These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 16530976

  • 1. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats.
    Carta M, Stancampiano R, Tronci E, Collu M, Usiello A, Morelli M, Fadda F.
    Neuroscience; 2006; 139(4):1163-72. PubMed ID: 16530976
    [Abstract] [Full Text] [Related]

  • 2. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM, Kreipke CW, Walker PD.
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [Abstract] [Full Text] [Related]

  • 3. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
    Strömberg I, Kehr J, Andbjer B, Fuxe K.
    Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
    [Abstract] [Full Text] [Related]

  • 4. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D, Osborn CV.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):88-94. PubMed ID: 16324697
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats.
    Glavan G, Zivin M.
    Neuroscience; 2005 Dec 28; 135(2):545-54. PubMed ID: 16111820
    [Abstract] [Full Text] [Related]

  • 7. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H, Sato H, Ida I, Oshima A, Sakurai N, Shihara N, Horikawa Y, Mikuni M.
    Pharmacol Biochem Behav; 2007 May 28; 87(1):56-64. PubMed ID: 17499349
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR, Frau L, Pinna A, Pontis S, Simola N, Schintu N, Morelli M.
    Synapse; 2008 Jul 28; 62(7):524-33. PubMed ID: 18435422
    [Abstract] [Full Text] [Related]

  • 11. Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
    Andersson DR, Björnsson E, Bergquist F, Nissbrandt H.
    Exp Neurol; 2010 Jan 28; 221(1):251-9. PubMed ID: 19944096
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T, Seeman P, Kuroiwa M, Nishi A.
    Eur J Neurosci; 2008 May 28; 27(10):2551-7. PubMed ID: 18489579
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
    Isacson R, Kull B, Wahlestedt C, Salmi P.
    Neuroscience; 2004 May 28; 124(1):33-42. PubMed ID: 14960337
    [Abstract] [Full Text] [Related]

  • 19. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.
    Imperato A, Obinu MC, Casu MA, Mascia MS, Dazzi L, Gessa GL.
    J Pharmacol Exp Ther; 1993 Aug 28; 266(2):557-62. PubMed ID: 8102643
    [Abstract] [Full Text] [Related]

  • 20. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.
    Kõks S, Volke V, Veraksits A, Rünkorg K, Sillat T, Abramov U, Bourin M, Huotari M, Männistö PT, Matsui T, Vasar E.
    Psychopharmacology (Berl); 2001 Nov 28; 158(2):198-204. PubMed ID: 11702094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.